Fortem Financial Group’s Medpace MEDP Stock Holding History

Fortem Financial Group’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-452	Closed	-$63K	–	331
2020 Q4	$63K	Buy	+452	New	+$57K	0.04%	222
2019 Q3	–	Sell	-4,690	Closed	-$307K	–	141
2019 Q2	$307K	Sell	4,690 -333	-7%	-$19.2K	0.31%	69
2019 Q1	$296K	Buy	5,023 +19	+0.4%	+$1.14K	0.31%	67
2018 Q4	$265K	Buy	+5,004	New	+$275K	0.32%	68

Other funds holding MEDP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Pendal Group Sydney, Australia $11.6B AUM 12.87% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fortem Financial Group's MEDP Position: Q1 2021 in Review

Fortem Financial Group sold out of Medpace (MEDP) in Q1 2021, closing a stake of 452 shares — an estimated $63K sold.

Fortem Financial Group first reported a position in MEDP in Q4 2018 and held it in 4 quarters. The position peaked at $307K in Q2 2019. 319 funds tracked by Wall St. Rank hold MEDP as of Q1 2021.

Fortem Financial Group reported no remaining Medpace position as of Q1 2021 after selling out during the quarter.
Fortem Financial Group sold 452 Medpace shares in Q1 2021, an estimated $63K.
Fortem Financial Group first reported a position in Medpace in Q4 2018 and held it in 4 quarters.
Fortem Financial Group's Medpace position peaked at $307K in Q2 2019.
319 funds tracked by Wall St. Rank held Medpace as of Q1 2021.

Based on Fortem Financial Group's 13F filing for Q1 2021, filed 20 Apr 2021.